시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 무세포동종진피(ADM) 시장 보고서(2025년)
Acellular Dermal Matrices Global Market Report 2025
상품코드 : 1760444
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,253,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,039,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,824,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

무세포동종진피(ADM) 시장 규모는 향후 수 년간 강력한 성장이 예상될 예정입니다. 최소 침습적 시술에 대한 수요 증가, 노인 인구 증가, 환자 맞춤형 ADM 솔루션에 대한 집중도 증가, 재건 수술 증가, 만성 질환의 유병률 증가에 의해 초래될 것으로 예측됩니다. 예측 기간 중에 예상되는 주요 동향에는 ADM과 저침습 수술의 통합, 조직공학의 진보, 줄기세포 치료의 흡수, 합성 ADM과 하이브리드 ADM의 개발, 양측 ADM과 메쉬 ADM 디자인의 혁신 등이 있습니다.

만성 상처 증가는 향후 수 년간 무세포동종진피(ADM) 시장의 성장을 크게 견인할 것으로 예측됩니다. 만성 상처 증가는 당뇨병 환자 증가와 밀접한 관계가 있습니다. 무세포동종진피(ADM)는 자연 조직 재생을 촉진하고 치유 과정을 앞당기는 발판이 되어 만성 창상 관리를 지원합니다. 670만명이 만성 상처를 앓고 있으며, 이 수는 향후 10년간 매년 2%씩 증가할 것으로 예측하고 있다고 보고했습니다.

무세포동종진피(ADM) 시장의 주요 기업은 수술의 다양성과 사용 편의성을 향상시키는 양면 이식편을 개발하고 제품 혁신에 주력하고 있습니다. 예를 들어 2023년 5월 미국을 거점으로 하여 의료조치용으로 인간 조직 유래의 동종이식편을 공급하는 비영리 단체인 AlloSource사는 AlloMend Duo Acellular Dermal Matrix(ADM)를 발표했습니다. 이 제품은 특히 부드러운 조직 재건을 위해 설계되었으며 외과 의사에게 부드러운 조직 결손을 복구하고 강화하기위한 신뢰할 수있는 옵션을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Acellular dermal matrices (ADMs) are natural materials derived from skin tissue that undergo processing to remove all cellular components. These materials are utilized in surgical procedures to repair or replace damaged tissues. Serving as a scaffold, ADMs promote the growth and healing of new tissue. They are commonly used in procedures such as breast reconstruction and wound healing to support the regeneration of skin and soft tissues.

The primary types of acellular dermal matrices include human acellular dermal matrices, porcine acellular dermal matrices, and other source-derived acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials obtained from donated human skin, with all cellular components removed, leaving behind a collagen-rich structure that aids in tissue regeneration during reconstructive and surgical procedures. These products are distributed through various channels, such as direct sales, online platforms, and distributor networks. They are employed in a range of applications, including breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.

The acellular dermal matrices market research report is one of a series of new reports from The Business Research Company that provides acellular dermal matrices market statistics, including the acellular dermal matrices industry global market size, regional shares, competitors with the acellular dermal matrices market share, detailed acellular dermal matrices market segments, market trends, and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. This acellular dermal matrices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The acellular dermal matrices market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historic period can be attributed to the increasing incidence of breast cancer and mastectomies, growth in reconstructive and cosmetic surgeries, expanding use in hernia and orthopedic repairs, rising awareness and acceptance of biologic grafts, and a surge in trauma and accident cases.

The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The projected growth in the forecast period is expected to be driven by a rising demand for minimally invasive procedures, an increasing geriatric population, a growing focus on patient-specific and customizable ADM solutions, a higher number of reconstructive surgeries, and the growing prevalence of chronic conditions. Key trends anticipated for the forecast period include the integration of ADMs with minimally invasive surgeries, advancements in tissue engineering, the incorporation of stem cell therapies, the development of synthetic and hybrid ADMs, and innovations in dual-sided and meshed ADM designs.

The rising number of chronic wounds is expected to significantly drive the growth of the acellular dermal matrices market in the coming years. Chronic wounds are injuries or sores that either heal very slowly or do not heal at all, often recurring and requiring specialized treatment. The growing prevalence of these wounds is closely linked to the increasing number of individuals with diabetes. Diabetes can impair blood circulation and damage nerves, making it more difficult for the body to heal even minor cuts, which can then develop into serious and persistent wounds. Acellular dermal matrices assist in managing chronic wounds by serving as a supportive scaffold that promotes natural tissue regeneration and speeds up the healing process. For example, in July 2023, OSF HealthCare, a nonprofit healthcare organization based in the U.S., reported that 6.7 million people in the country are currently affected by chronic wounds, with this number projected to grow by 2% annually over the next ten years. Therefore, the increasing prevalence of chronic wounds is fueling the expansion of the acellular dermal matrices market.

Leading companies in the acellular dermal matrices market are focusing on product innovation by developing dual-sided grafts to improve surgical versatility and ease of use. Dual-sided acellular dermal matrices are advanced grafts designed with two functional surfaces, allowing for more flexible implantation and streamlined handling during surgery. For instance, in May 2023, AlloSource, a U.S.-based nonprofit organization that supplies allografts derived from human tissue for medical procedures, introduced AlloMend Duo Acellular Dermal Matrix (ADM). This product is designed specifically for soft tissue reconstruction, offering surgeons a dependable option for restoring and reinforcing soft tissue defects. The deep reticular dermal allograft is engineered to integrate well with surrounding tissues, providing a scaffold that encourages cellular repopulation and the regeneration of native tissue.

In March 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, entered into a partnership with Sientra Inc. to broaden access to biologic solutions for soft tissue reconstruction. This collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, to support procedures such as breast reconstruction. The initiative is aimed at improving access to biologic products for women undergoing reconstructive surgery. Sientra Inc. is a U.S.-based medical aesthetics company that produces silicone breast implants and other products for cosmetic and reconstructive breast procedures.

Major players in the acellular dermal matrices market are Johnson & Johnson, AbbVie Inc., Becton Dickinson and Company, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Conmed, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG bio Inc., and Meccellis Biotech.

North America was the largest region in the acellular dermal matrices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acellular dermal matrices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acellular dermal matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acellular Dermal Matrices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acellular dermal matrices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for acellular dermal matrices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acellular dermal matrices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Acellular Dermal Matrices Market Characteristics

3. Acellular Dermal Matrices Market Trends And Strategies

4. Acellular Dermal Matrices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Acellular Dermal Matrices Growth Analysis And Strategic Analysis Framework

6. Acellular Dermal Matrices Market Segmentation

7. Acellular Dermal Matrices Market Regional And Country Analysis

8. Asia-Pacific Acellular Dermal Matrices Market

9. China Acellular Dermal Matrices Market

10. India Acellular Dermal Matrices Market

11. Japan Acellular Dermal Matrices Market

12. Australia Acellular Dermal Matrices Market

13. Indonesia Acellular Dermal Matrices Market

14. South Korea Acellular Dermal Matrices Market

15. Western Europe Acellular Dermal Matrices Market

16. UK Acellular Dermal Matrices Market

17. Germany Acellular Dermal Matrices Market

18. France Acellular Dermal Matrices Market

19. Italy Acellular Dermal Matrices Market

20. Spain Acellular Dermal Matrices Market

21. Eastern Europe Acellular Dermal Matrices Market

22. Russia Acellular Dermal Matrices Market

23. North America Acellular Dermal Matrices Market

24. USA Acellular Dermal Matrices Market

25. Canada Acellular Dermal Matrices Market

26. South America Acellular Dermal Matrices Market

27. Brazil Acellular Dermal Matrices Market

28. Middle East Acellular Dermal Matrices Market

29. Africa Acellular Dermal Matrices Market

30. Acellular Dermal Matrices Market Competitive Landscape And Company Profiles

31. Acellular Dermal Matrices Market Other Major And Innovative Companies

32. Global Acellular Dermal Matrices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acellular Dermal Matrices Market

34. Recent Developments In The Acellular Dermal Matrices Market

35. Acellular Dermal Matrices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기